Apoha's core product is VIBE® (Variations in Inter-facial Behaviour Under Excitation), an empirical readout that captures wave patterns from minute samples suspended in liquid and subjected to controlled stresses to produce over 1,000 measured descriptors of molecular behaviour. The company says a VIBE readout can resolve many properties simultaneously within minutes and has been applied across pharma, food and materials. Apoha reports commercial collaborations and validation with partners including Boehringer Ingelheim, Ethris, plant-based food company THIS, Somru BioSciences and multiple Fortune 500 customers. The underlying science dates to research begun in 2008 by CEO Shamit Shrivastava and the company was co-founded in 2021 with COO Anshika Srivastava. Apoha holds more than 60 patents and its foundational discovery has been cited in the scientific literature over 1,500 times. The company is positioning its platform as a data layer to improve prediction, reduce late-stage failures and accelerate product development across multiple industries.

Total raised

$37M

Funding rounds

3

Latest round

Series A

Latest activity

Jun 2026